Gangolli Julian S
Director at KRYS; President, North America at GW PHARMACEUTICALS PLC; CVP & Pres, North America at ALLERGAN INC
- Sold, on record
- $27.4M
- Dollars the filings state
- Form 4 sales
- 5
- Latest May 20, 2024
- Form 144 notices
- 1
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- KRYSKrystal Biotech, Inc.Director
- GW PHARMACEUTICALS PLCPresident, North America
- ALLERGAN INCCVP & Pres, North America
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- GW PHARMACEUTICALS PLC677,928 shares
- ALLERGAN INC142,500 shares
- KRYS20,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ALLERGAN INCUnusualNov 28, 2012 2012
Sold 90,000 shares at $91.89 ($8.3M)
Gangolli Julian S, CVP & Pres, North America
Sold 85.1% of holdings ($9.7M position)15,781 shares leftFirst sale on recordFiling
- 2 Form 4 sale ALLERGAN INCUnusualDec 27, 2013 +394 days
Sold 52,500 shares at $110.05 ($5.8M)
Gangolli Julian S, CVP & Pres, North America
Sold 86.7% of holdings ($6.7M position)8,047 shares leftFiling
- 3 Form 4 sale GW PHARMACEUTICALS PLCPlan not statedFeb 26, 2019 +1887 days
Sold 6,000 shares at $12.45 ($75k)
Gangolli Julian S, President, North America
Sold 5.3% of holdings ($1.4M position)106,548 shares leftFirst sale on recordFiling
- 4 Form 4 sale GW PHARMACEUTICALS PLCUnusualMay 10, 2019 +73 days
Sold 671,928 shares at $14.84 ($10M)
Gangolli Julian S, President, North America
Sold 86.3% of holdings ($11.6M position)106,548 shares leftFiling
- 5 Form 144 notice KRYSNoticeMay 20, 2024 +1837 days
Filed to sell 20,000 shares ($3.3M)
Gangolli Julian S, Director
No 10b5-1 planFirst sale on recordFiling
- 6 Form 4 sale KRYSUnusualMay 20, 2024 same day
Sold 20,000 shares at $164.14 ($3.3M)
Gangolli Julian S, Director
No 10b5-1 planSold 100% of holdings ($3.3M position)0 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2024 | May 22, 2024 | KRYS | Director | Form 4 sale | 20,000 | $3.3M | 100.0% | Unusual | SEC |
| May 20, 2024 | May 20, 2024 | KRYS | Director | Form 144 notice | 20,000 | $3.3M | Notice | SEC | |
| May 10, 2019 | May 14, 2019 | GW PHARMACEUTICALS PLC | President, North America | Form 4 sale | 671,928 | $10M | 86.3% | Unusual | SEC |
| Feb 26, 2019 | Feb 28, 2019 | GW PHARMACEUTICALS PLC | President, North America | Form 4 sale | 6,000 | $75k | 5.3% | Plan not stated | SEC |
| Dec 27, 2013 | Dec 30, 2013 | ALLERGAN INC | CVP & Pres, North America | Form 4 sale | 52,500 | $5.8M | 86.7% | Unusual | SEC |
| Nov 28, 2012 | Nov 29, 2012 | ALLERGAN INC | CVP & Pres, North America | Form 4 sale | 90,000 | $8.3M | 85.1% | Unusual | SEC |